Delivering on its commitment to advance and optimise clinical diagnostic laboratories, Beckman Coulter has launched a new benchtop haematology analyser for mid- to high-volume laboratories. Building on the company’s proven cellular analysis technology, Beckman Coulter’s UniCel DxH 600 Coulter cellular analysis system provides laboratories with exceptional quality results, improved first-pass accuracy and automatic rerun and reflex testing, thereby reducing overall manual review rates and processes.
The haematology laboratory’s single most important step, and most time-consuming, is the manual review. By reducing manual differential rates, the new analyser frees mid- to high-volume laboratories to focus time on quickly and accurately reporting patient results, improving patient health and reducing the overall cost of care.
"This new haematology analyser has the ability to transform the haematology laboratory, with unparalleled efficiency, revolutionary scalability and quality of results,“ said Leanne Annereau, Beckman Coulter’s marketing manager, Northern Region, Europe. “The UniCel DxH 600 advances the technology that made Coulter systems the worldwide market leader in haematology and will change how departments manage their cellular analysis process.”
The company has also introduced an advanced version of the innovative CytoDiff CXP Autogating software, which is an integral part of its HematoFlow solution — combining diagnostic reagent, haematology hardware and IT expertise. The introduction of Version 2 CytoDiff CXP Autogating software is designed to give laboratories added confidence in the use of flow cytometry in the routine haematology laboratory for the auto-validation of abnormal samples.
Easy-to-use, the advanced Version 2 software improves subpopulation classifications. It adds new features, such as greater precision in the removal of potential interference and metrics that provide a new ‘confidence level’ on population classification. The new software simplifies the review process, making it easier to validate results with greater certainty.
www.beckmancoulter.com
